{"id":"W2943834628","doi":"10.1158/1538-7445.sabcs18-pd2-04","title":"Abstract PD2-04: Baseline circulating <i>ESR1</i> mutation analysis in the randomised phase III EFECT study of fulvestrant versus exemestane in advanced hormone receptor positive breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Medicine; Internal medicine; Oncology; Aromatase inhibitor; Breast cancer; Hazard ratio; Metastatic breast cancer; Cancer; Triptorelin; Estrogen receptor; Gynecology; Aromatase; Gastroenterology; Confidence interval; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003666122,0.0008646622,0.001927296,0.000252682,0.0002046298,0.0009189594,0.0005732898,0.0008825227,0.003386714],"category_scores_gemma":[0.002428811,0.0004249776,0.001392176,0.000349989,0.0007035,0.0005564149,0.0003288557,0.002194199,0.0003710763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006500906,"about_ca_system_score_gemma":0.0008698041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003439639,"about_ca_topic_score_gemma":0.0006863147,"domain_scores_codex":[0.9985723,0.0009570777,0.00008487389,0.0001621399,0.000124874,0.00009870702],"domain_scores_gemma":[0.9984664,0.0005146008,0.0003948212,0.0001472828,0.0001174366,0.0003594747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9664257,0.002994456,0.007465544,0.0002535821,0.0009430166,0.0000433544,0.00003117927,0.000589687,0.006772365,0.00005133019,0.0009729654,0.01345697],"study_design_scores_gemma":[0.7246547,0.2268869,0.03843932,0.00003308254,0.00151729,0.0002155373,0.00003798394,0.001480507,0.004548551,0.0002549532,0.001898688,0.00003243651],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938173,0.001857199,0.0006030677,0.0003917504,0.0001556234,0.0007621535,0.001455195,0.0000487208,0.0009090528],"genre_scores_gemma":[0.9951019,0.0004194684,0.0007643278,0.0004040599,0.0001246058,0.0006691021,0.001488524,0.00001130129,0.001016721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003666122,"threshold_uncertainty_score":0.0193885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04074556143826198,"score_gpt":0.4134207069088296,"score_spread":0.3726751454705676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}